AskBio Phase Ib Trial of AB-1005 Gene Therapy in Patients with Parkinson ’s Disease Meets Primary Endpoint
Berlin, Germany/Research Triangle Park, North Carolina, USA, January 4, 2024– Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced today...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | Gene Therapy | Genetics | Germany Health | Parkinson's Disease | Pharmaceuticals